These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 2827480)
1. Pituitary responses to synthetic corticotropin-releasing hormone: absence of modulatory effects by estrogen and progestin. Liu JH; Rasmussen DD; Rivier J; Vale W; Yen SS Am J Obstet Gynecol; 1987 Dec; 157(6):1387-91. PubMed ID: 2827480 [TBL] [Abstract][Full Text] [Related]
2. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man. Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406 [TBL] [Abstract][Full Text] [Related]
3. Progestin treatment in the dog. II. Effects on the hypothalamic-pituitary-adrenocortical axis. Selman PJ; Mol JA; Rutteman GR; Rijnberk A Eur J Endocrinol; 1994 Oct; 131(4):422-30. PubMed ID: 7921232 [TBL] [Abstract][Full Text] [Related]
4. Influence of the hypothalamic-pituitary-adrenal axis on the menstrual cycle and the pituitary responsiveness to estradiol in the female rhesus monkey (Macaca mulatta). Hayashi KT; Moberg GP Biol Reprod; 1990 Feb; 42(2):260-5. PubMed ID: 2159808 [TBL] [Abstract][Full Text] [Related]
5. Hypothalamo-pituitary-adrenal axis and adrenal function before and after ovariectomy in premenopausal women. De Leo V; la Marca A; Talluri B; D'Antona D; Morgante G Eur J Endocrinol; 1998 Apr; 138(4):430-5. PubMed ID: 9578512 [TBL] [Abstract][Full Text] [Related]
6. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone. Sawin CT; Hershman JM; Boyd AE; Longcope C; Bacharach P J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427 [TBL] [Abstract][Full Text] [Related]
7. Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome. Rabin DS; Schmidt PJ; Campbell G; Gold PW; Jensvold M; Rubinow DR; Chrousos GP J Clin Endocrinol Metab; 1990 Nov; 71(5):1158-62. PubMed ID: 2172272 [TBL] [Abstract][Full Text] [Related]
8. Effects of progestin administration on the hypothalamic-pituitary-adrenal axis and glucose homeostasis in dogs. Selman PJ; Mol JA; Rutteman GR; van Garderen E; van den Ingh TS; Rijnberk A J Reprod Fertil Suppl; 1997; 51():345-54. PubMed ID: 9404305 [TBL] [Abstract][Full Text] [Related]
10. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment. Kudielka BM; Schmidt-Reinwald AK; Hellhammer DH; Kirschbaum C Neuroendocrinology; 1999 Dec; 70(6):422-30. PubMed ID: 10657735 [TBL] [Abstract][Full Text] [Related]
11. Modulatory role of estrogens and progestins on growth hormone episodic release in women with hypothalamic amenorrhea. Genazzani AD; Petraglia F; Volpogni C; Gastaldi M; Pianazzi F; Montanini V; Genazzani AR Fertil Steril; 1993 Sep; 60(3):465-70. PubMed ID: 8375528 [TBL] [Abstract][Full Text] [Related]
12. Tamoxifen is an estrogen antagonist on gonadotropin secretion and responsiveness of the hypothalamic-pituitary- adrenal axis in female monkeys. Wilson ME; Mook D; Graves F; Felger J; Bielsky IF; Wallen K Endocrine; 2003 Dec; 22(3):305-15. PubMed ID: 14709804 [TBL] [Abstract][Full Text] [Related]
13. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353 [TBL] [Abstract][Full Text] [Related]
14. Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea. Biller BM; Federoff HJ; Koenig JI; Klibanski A J Clin Endocrinol Metab; 1990 Feb; 70(2):311-7. PubMed ID: 2153693 [TBL] [Abstract][Full Text] [Related]
15. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. Schlaghecke R; Kornely E; Santen RT; Ridderskamp P N Engl J Med; 1992 Jan; 326(4):226-30. PubMed ID: 1309389 [TBL] [Abstract][Full Text] [Related]
16. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation. Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625 [TBL] [Abstract][Full Text] [Related]
17. Hormonal effects on epilepsy in women. Klein P; Herzog AG Epilepsia; 1998; 39 Suppl 8():S9-16. PubMed ID: 9915615 [TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing factor--induced adrenocorticotropic hormone release in the sheep fetus: blockade by cortisol. Rose JC; Hargrave BY; Dix PM; Meis PJ; LaFave M; Torpe B Am J Obstet Gynecol; 1985 Apr; 151(8):1128-33. PubMed ID: 2984937 [TBL] [Abstract][Full Text] [Related]
19. Effects of pyridostigmine, corticotropin-releasing hormone and growth hormone-releasing hormone on the pituitary-adrenal axis and on growth hormone secretion in dementia. Murialdo G; Fonzi S; Torre F; Costelli P; Solinas G; Tosca P; Di Paolo E; Porro S; Zerbi F; Polleri A Neuropsychobiology; 1993; 28(4):177-83. PubMed ID: 8272199 [TBL] [Abstract][Full Text] [Related]
20. The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey. Roy BN; Reid RL; Van Vugt DA Endocrinology; 1999 May; 140(5):2191-8. PubMed ID: 10218971 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]